Ident. | Authors (with country if any) | Title |
---|
000234 (2013) |
David R. Fox [Australie] ; Elise Billoir [France] | Time‐dependent species sensitivity distributions |
000484 (2012) |
David R. Fox [Australie] ; Elise Billoir [France] ; Sandrine Charles [France] ; Marie Laure Delignette-Muller [France] ; Christelle Lopes [France] | What to do with NOECS/NOELS—prohibition or innovation? |
000628 (2012) |
Emmanuelle Bazin [France] ; Sylvie Huet [France] ; Gérard Jarry [France] ; Ludovic Le Hégarat [France] ; John S. Munday [Nouvelle-Zélande] ; Andrew R. Humpage [Australie] ; Valérie Fessard [France] | Cytotoxic and genotoxic effects of cylindrospermopsin in mice treated by gavage or intraperitoneal injection |
000709 (2011) |
Alessandro Testori [Italie] ; Cornelis Verhoef [Pays-Bas] ; Hidde M. Kroon [Pays-Bas] ; E. Pennacchioli [Italie] ; Mark B. Faries [États-Unis] ; Alexander M. M. Eggermont [France] ; John F. Thompson [Australie] | Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion |
000828 (2011) |
David R. Fox [Australie] ; Elise Billoir [France] | Individual versus population effects in concentration‐response modeling |
000836 (2011) |
Ralf Jochmann [Suisse] ; Wolf U. Blanckenhorn [Suisse] ; Luc Bussière [Royaume-Uni] ; Charles E. Eirkson [États-Unis] ; John Jensen [Danemark] ; Ute Kryger [Afrique du Sud] ; Joost Lahr [Pays-Bas] ; Jean-Pierre Lumaret [France] ; Jörg Römbke [Allemagne] ; Keith G. Wardhaugh [Australie] ; Kevin D. Floate [Canada] | How to test nontarget effects of veterinary pharmaceutical residues in livestock dung in the field |
000886 (2011) |
Viviane Bouilleret [Australie, France] ; Lisa Cardamone [Australie] ; Cyril Liu [Australie] ; Amelia S. Koe [Australie] ; Ke Fang [Australie] ; John P. Williams [Australie] ; Damian E. Myers [Australie] ; Terence J. O'Brien [Australie] ; Nigel C. Jones [Australie] | Confounding neurodegenerative effects of manganese for in vivo MR imaging in rat models of brain insults |
000B20 (2010) |
Badrish Soni [France, Inde, Australie] ; Nishant P. Visavadiya [Inde, États-Unis] ; Nirav Dalwadi [Inde] ; Datta Madamwar [Inde] ; Chris Winder [Australie] ; Christian Khalil [Australie] | Purified c‐phycoerythrin: safety studies in rats and protective role against permanganate‐mediated fibroblast‐DNA damage |
000B48 (2010) |
Victoria E. Shaw [Australie] ; Sharon Spana [Australie] ; Keyoumars Ashkan [Royaume-Uni] ; Alim-Louis Benabid [France] ; Jonathan Stone [Australie] ; Gary E. Baker [Royaume-Uni] ; John Mitrofanis [Australie] | Neuroprotection of midbrain dopaminergic cells in MPTP‐treated mice after near‐infrared light treatment |
000B61 (2010) |
Valeria Santini [Italie] ; Pierre Fenaux [France] ; Ghulam J. Mufti [Royaume-Uni] ; Eva Hellström-Lindberg [Suède] ; Lewis R. Silverman [États-Unis] ; Alan List [États-Unis] ; Steven D. Gore [États-Unis] ; John F. Seymour [Australie] ; Jay Backstrom [États-Unis] ; Charles L. Beach [États-Unis] | Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine |
000B94 (2010) |
Emmanuelle Bazin [France] ; Annick Mourot [France] ; Andrew R. Humpage [Australie] ; Valérie Fessard [France] | Genotoxicity of a freshwater cyanotoxin, cylindrospermopsin, in two human cell lines: Caco‐2 and HepaRG |
000C15 (2010) |
Anette Küster [Allemagne] ; Alfredo C. Alder [Suisse] ; Beate I. Escher [Suisse, Australie] ; Karen Duis [Allemagne] ; Kathrin Fenner [Suisse] ; Jeanne Garric [France] ; Thomas H. Hutchinson [Royaume-Uni] ; David R. Lapen [Canada] ; Alexandre Péry [France] ; Jörg Römbke [Allemagne] ; Jason Snape [Royaume-Uni] ; Thomas Ternes [Allemagne] ; Ed Topp [Canada] ; Anne Wehrhan [Allemagne, Suisse] ; Thomas Knacker [Allemagne] | Environmental risk assessment of human pharmaceuticals in the European Union: A case study with the β‐blocker atenolol |
000C16 (2010) |
Ken D. Oakes [Canada] ; Anja Coors [Allemagne] ; Beate I. Escher [Suisse, Australie] ; Kathrin Fenner [Suisse] ; Jeanne Garric [France] ; Marion Gust [France] ; Thomas Knacker [Allemagne] ; Anette Küster [Allemagne] ; Carola Kussatz [Allemagne] ; Chris D. Metcalfe [Canada] ; Sara Monteiro [Royaume-Uni] ; Thomas W. Moon [Canada] ; Jan A. Mennigen [Canada] ; Joanne Parrott [Canada] ; Alexandre Rr Péry [France] ; Maria Ramil [Allemagne] ; Ines Roennefahrt [Allemagne] ; José V. Tarazona [Espagne] ; Paloma Sánchez-Argüello [Espagne] ; Thomas A. Ternes [Allemagne] ; Vance L. Trudeau [Canada] ; Tatiana Boucard [Royaume-Uni] ; Glen J. Van Der Kraak [Canada] ; Mark R. Servos [Canada] | Environmental risk assessment for the serotonin re‐uptake inhibitor fluoxetine: Case study using the European risk assessment framework |
000C49 (2010) |
Oscar Acosta [France] ; Jason Dowling [Australie] ; Guillaume Cazoulat [France] ; Antoine Simon [France] ; Olivier Salvado [Australie] ; Renaud De Crevoisier [France] ; Pascal Haigron [France] | Atlas Based Segmentation and Mapping of Organs at Risk from Planning CT for the Development of Voxel-Wise Predictive Models of Toxicity in Prostate Radiotherapy |
000D71 (2009) |
Stefano L. Sensi [Italie, États-Unis] ; Pierre Paoletti [France] ; Ashley I. Bush [Australie, États-Unis] ; Israel Sekler [Israël] | Zinc in the physiology and pathology of the CNS |
000E58 (2009) |
K. Visser [Pays-Bas] ; W. Katchamart [Canada] ; E. Loza [Espagne] ; J A Martinez-Lopez [Espagne] ; C. Salliot [France] ; J. Trudeau [Canada] ; C. Bombardier [Canada] ; L. Carmona [Espagne] ; D. Van Der Heijde [Pays-Bas] ; J W J. Bijlsma [Pays-Bas] ; D T Boumpas [Grèce] ; H. Canhao [Portugal] ; C J Edwards [Royaume-Uni] ; V. Hamuryudan [Turquie] ; T K Kvien [Norvège] ; B F Leeb [Autriche] ; E M Martín-Mola [Espagne] ; H. Mielants [Belgique] ; U. Müller-Ladner [Allemagne] ; G. Murphy [Irlande (pays)] ; M. Stergaard [Danemark] ; I A Pereira [Brésil] ; C. Ramos-Remus [Mexique] ; G. Valentini [Italie] ; J. Zochling [Australie] ; M. Dougados [France] | Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative |
000E70 (2009) |
Edward A. Stadtmauer [États-Unis] ; Donna M. Weber [États-Unis] ; Ruben Niesvizky [États-Unis] ; Andrew Belch [Canada] ; Miles H. Prince [Australie] ; Jesús F. San Miguel [Espagne] ; Thierry Facon [France] ; Marta Olesnyckyj [États-Unis] ; Zhinuan Yu [États-Unis] ; Jerome B. Zeldis [États-Unis] ; Robert D. Knight [États-Unis] ; Meletios A. Dimopoulos [Grèce] | Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma |
001150 (2008) |
D M Burns [États-Unis] ; E. Dybing [Norvège] ; N. Gray [Australie] ; S. Hecht [États-Unis] ; C. Anderson [États-Unis] ; T. Sanner [Norvège] ; R. O Onnor [États-Unis] ; M. Djordjevic [États-Unis] ; C. Dresler [États-Unis] ; P. Hainaut [France] ; M. Jarvis [Royaume-Uni] ; A. Opperhuizen [Pays-Bas] ; K. Straif [France] | Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal |
001171 (2008) |
E. Kazakou [Grèce, France] ; P. G. Dimitrakopoulos [Grèce] ; A. J. M. Baker [Australie] ; R. D. Reeves [Australie] ; A. Y. Troumbis [Grèce] | Hypotheses, mechanisms and trade‐offs of tolerance and adaptation to serpentine soils: from species to ecosystem level |
001456 (2007) |
Andrew R. Humpage [Australie] ; Aurélie Ledreux [France] ; Stella Fanok [Australie] ; Cécile Bernard [France] ; Jean-François Briand [France] ; Geoff Eaglesham [Australie] ; John Papageorgiou [Australie] ; Brenton Nicholson [Australie] ; Dennis Steffensen [Australie] | Application of the neuroblastoma assay for paralytic shellfish poisons to neurotoxic freshwater cyanobacteria: Interlaboratory calibration and comparison with other methods of analysis |
001675 (2006) |
J. Zochling [Australie] ; D. Van Der Heijde [Pays-Bas] ; M. Dougados [France] ; J. Braun [Allemagne] | Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis |